Françoise Piguet

Dr. Françoise PIGUET is heading a research team (TIDU-Genov’) in Paris Brain institute focused on development of gene therapy approaches for neurodegenerative diseases. 

Since 2006, she contributed to the field of neurodegenerative diseases and development of AAV based- gene therapy approaches first on metachromatic leukodystrophy, Huntington and Friedreich Ataxia. She previously developed a clinical trial on metachromatic leukodystrophy and patent a gene therapy approach for Friedreich Ataxia as well as for Rett syndrome, MLD and ALS. 

More recently, Françoise is working on development of new routes of delivery to efficiently target the central and peripheral nervous system.